Drug factory · FDA FEI 3009798720

Wickham Micro Limited

Hoeford Point Barwell Lane, Gosport, United Kingdom

United Kingdom: 1

Problems found, fixed voluntarily at FDA's last inspection, Feb 2, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2011: 0 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AmikacinTests it Insmed Incorporated 71558-590
ApomorphineTests it MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. 27505-004
BuprenorphineTests it Indivior Inc. 12496-0100, 12496-0300
SelexipagTests it Actelion Pharmaceuticals US, Inc. 66215-718

FDA inspection history

EndedResultProgramProblems noted
Feb 2, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 27, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 27, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 17, 2016Problems found, fixed voluntarilyDrug Quality Assurance4
Mar 3, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Feb 17, 2016 inspection

Registered with FDA for: analysis.